RF
BLFS icon

Rossby Financial’s BioLife Solutions BLFS Stock Holding History

Rossby Financial’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8
Closed -$154 – 2164
2026
Q1 		$154 Buy
+8
New +$177 ﹤0.01% 2213

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Rossby Financial's BLFS Position: Q2 2026 in Review

Rossby Financial sold out of BioLife Solutions (BLFS) in Q2 2026, closing a stake of 8 shares — an estimated $154 sold.

Rossby Financial first reported a position in BLFS in Q1 2026 and held it in 1 quarter. The position peaked at $154 in Q1 2026. 217 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Rossby Financial reported no remaining BioLife Solutions position as of Q2 2026 after selling out during the quarter.
  • Rossby Financial sold 8 BioLife Solutions shares in Q2 2026, an estimated $154.
  • Rossby Financial first reported a position in BioLife Solutions in Q1 2026 and held it in 1 quarter.
  • Rossby Financial's BioLife Solutions position peaked at $154 in Q1 2026.
  • 217 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.